Investors typically like it when stocks catch an upgrade. Similarly, a downgrade can send shares lower. That isn’t exactly how things are working out for U.S. chemical stocks after ratings changes from BofA Securities. ...

DuPont de Nemours, Inc. (DD) is benefiting from innovation-driven investment and its productivity and pricing actions. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.Let’s take a look into the factors that make this Zacks Rank #2 (Buy) stock an attractive choice for investors right now.Healthy Growth ProspectsThe Zacks Consensus Estimate for earnings for 2024 for DuPont is cur ...

WILMINGTON, Del., Jan. 10, 2024 /PRNewswire/ -- DuPont™ Tedlar® and the SPE (Society of Plastic Engineers) Foundation announced that two students have been awarded the DuPont™ Tedlar® Scholarship for academic study focused on plastics engineering. Each scholarship recipient received $2,500 to support their studies in STEM. The scholarships are part of a year-long partnership between DuPont™ Tedlar® and SPE to support the Foundation's three-pronged approach to enrich and develop the future workforce for plas ...

DuPont de Nemours, Inc. (DD) is expected to benefit from its innovation-driven investment, productivity and pricing actions and the Spectrum Plastics Group acquisition amid certain challenges including weaker demand in specific businesses.The company’s shares are up 4.4% over a year against a 10.1% decline of its industry. Image Source: Zacks Investment ResearchLet’s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment. Productivity, Innovation & Spectrum Buyout to Aid ResultsDuPont ...

DuPont de Nemours, Inc. (NYSE:DD) Q3 2023 Earnings Conference Call November 1, 2023 8:00 AM ET Company Participants Chris Mecray - VP, IR Ed Breen - CEO Lori Koch - CFO Conference Call Participants Jeff Sprague - Vertical Research Partners Scott Davis - Melius Research Steve Tusa - JPMorgan Mike Leithead - Barclays John McNulty - BMO Capital Markets David Begleiter - Deutsche Bank Aleksey Yefremov - KeyBanc Capital Markets Josh Spector - UBS Vincent Andrews - Morgan Stanley Frank Mitsch - Fermium Research A ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 September 30, 2023 For the quarterly period ended or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as specified in its charter) Delaware 81-1224539 State or other jurisdiction of incorporation or organization (I ...

2Q 2023 Financial Results Non-GAAPFinancialMeasures:Unlessotherwiseindicated,allfinancialmetricspresentedanddiscussionofresultsreflectcontinuingoperationsonly. Thiscommunicationincludesinformationthatdoesnotconform toaccountingprinciplesgenerallyacceptedintheUnitedStatesofAmerica(“U.S.GAAP”)andareconsiderednon-GAAPmeasures.Managementusesthesemeasuresinternallyforplanning, forecasting and evaluating the performance of the Company, including allocating resources. DuPont’s management believes these non-GAAP fi ...

DuPont de Nemours, Inc. (NYSE:DD) Q2 2023 Earnings Conference Call August 2, 2023 8:00 AM ET Company Participants Chris Mecray - Vice President, Investor Relations Ed Breen - Chief Executive Officer Lori Koch - Chief Financial Officer Conference Call Participants Bhavesh Lodaya - BMO Capital Markets Christopher Parkinson - Mizuho Securities John Roberts - Credit Suisse Steve Tusa - JPMorgan David Begleiter - Deutsche Bank Mike Leithead - Barclays Josh Spector - UBS Vincent Andrews - Morgan Stanley Frank Mit ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 30, 2023 For the quarterly period ended or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as specified in its charter) Delaware 81-1224539 State or other jurisdiction of incorporation or organization (I.R.S. ...

Financial Data and Key Metrics - Q1 2023 net sales decreased by 8% YoY to $3 billion, with a 3% organic decline [18] - Operating EBITDA declined by 13% YoY to $714 million, with a margin of 23.7%, down 130 basis points [20] - Adjusted EPS increased by 2% YoY to $0.84 per share [22] - Free cash flow was $102 million, impacted by $75 million in transaction costs related to the M&M deal and Delrin divestiture [21] Business Line Performance - Electronics & Industrial (E&I) segment sales declined by 16% YoY to $1.3 billion, driven by a 15% volume drop, particularly in Interconnect Solutions (down 21%) and Semiconductor Technologies (down mid-teens) [23] - Water & Protection (W&P) segment sales increased by 1% YoY to $1.45 billion, with Water Solutions up low double digits and Safety Solutions up mid-single digits [25] - Shelter Solutions within W&P declined mid-single digits due to softness in construction markets [25] Market Performance - North America sales increased by 1% YoY, Europe by 5%, while Asia Pacific declined by 10%, with China down nearly 20% due to electronics weakness [19] - Electronics and construction end markets saw high-teens volume declines, while other businesses grew low single digits [19] Strategic Direction and Industry Competition - The company announced the acquisition of Spectrum for $1.75 billion, expanding its healthcare portfolio and reducing cyclicality [7][8] - Spectrum is expected to generate $500 million in revenue in 2023 and grow at high single-digit rates, complementing DuPont's existing healthcare businesses [8][10] - The acquisition is expected to deliver high single-digit ROIC by year five, with $20 million in cost synergies [13] Management Commentary on Operating Environment and Future Outlook - Management expects ongoing strength in water, automotive, aerospace, and healthcare markets, with electronics recovery anticipated in Q3 2023 [26][27] - Full-year 2023 guidance includes net sales of $12.3-$12.5 billion, operating EBITDA of $3-$3.1 billion, and adjusted EPS of $3.55-$3.70 [28] - The company is focused on optimizing cash flow and minimizing volume pressure in the near term [6] Other Important Information - The company completed a $5 billion share repurchase authorization and reduced debt by $2.5 billion, with no significant debt maturities until November 2025 [14][15] - Net leverage is expected to finish the year around 2x, in line with multi-industrial peers [16] - The company published its annual sustainability report, highlighting progress on ESG goals, including a 30% reduction in Scope 1 and 2 greenhouse gas emissions [29][30] Q&A Session Summary Share Repurchases and Delrin Divestiture - The company has $2 billion left in its share repurchase program, with completion expected by Q1 2024 [34] - Delrin divestiture is expected to close by year-end 2023, with EBIT of $180 million [35] Pricing and Cost Outlook - Pricing in Q1 was 4%, with 6% in W&P, expected to decelerate to 1% overall in Q2 [38] - The company has not changed its $100 million price-cost spread assumption for 2023 [37] M&A and Capital Allocation - No significant M&A activity is expected in the near term, with a focus on completing the Spectrum acquisition [41] - The company may lean towards additional share repurchases with excess cash [42] Electronics Market Recovery - The electronics downturn is expected to last 3-4 quarters, with recovery anticipated in Q3 2023 [44][45] - Inventory destocking is expected to moderate in Q2, with recovery in Q3 and Q4 [110] Spectrum Acquisition and Margin Expansion - Spectrum's EBITDA margin is expected to improve by 300 basis points as new production capacity is utilized [51][52] - The acquisition is expected to deliver high single-digit ROIC, with potential for additional cost synergies [48][49] Water and Safety Business Resilience - Water Solutions and Safety Solutions are expected to remain strong, driven by secular trends in water filtration and healthcare packaging [58] - The EV market is also contributing to growth in the Safety Solutions segment [58] Raw Material Costs - Raw material costs have not yet seen significant declines, with potential upside in H2 2023 as prices adjust [93][95] PFAS Litigation Update - The company is in regular discussions with plaintiffs regarding the upcoming PFAS trial in Florida [100] Construction Market Weakness - North American construction markets, including residential and commercial, saw similar volume declines, with no significant recovery expected in 2023 [102]